Visual Outcome And Patient Satisfaction Of Extended Depth-Of-Focus Intraocular Lens Implantation In Eyes With And Without Macular Pathology

To compare the visual outcomes of the implantation of extended depth of focus (EDOF) intraocular lens (IOL) in patients with and without macular pathology

Ophthalmology department, Hillel Yaffe medical center, Hadera, Israel

A retrospective comparative study of patients with and without macular pathology who underwent cataract surgery and were implanted with either nondiffractive wavefront-shaping EDOF IOL (AcrySof IQ Vivity) or refractive aspheric hybrid EDOF IOL (LUCIDIS) over a 3 years period. Corrected distance visual acuity (CDVA), distance-corrected near visual acuity, defocus curve, contrast sensitivity, central foveal thickness, VF-14 questionnaire results, and quality of life where available were analyzed.

A total of 42 eyes of 25 patients were included in this study. 22 eyes of 15 patients had macular pathology (group 1) and 20 eyes of 10 patients without macular pathology (group 2). In group 1, 13 eyes had epiretinal membrane (ERM), 4 eyeshad submacular drusen, 3 eyes had combined ERM and submacular drusen and 2 eyes  had ERM and vitreomacular adhesions. Mean patient preoperative CDVA was logMAR 0.22 in group 1 and logMAR 0.44 in group 2. Postoperative monocular CDVA was logMAR 0.14 in group 1 and logMAR 0.1 in group 2. Eyes achieved a contrast sensitivity within the normal range. On postoperative VF-14 questionnaire, patients reported minimal visual impairment and were satisfied with the improvement in quality of life postoperatively.

The EDOF IOL lens implantation in patients with mild macular pathology is safe and resulted in a good patient satisfaction with a mild limitation in contrast sensitivity and improvement in quality of life .